|
Dear Colleague,
On behalf of Genomic Health, Inc., it is my pleasure to invite you to participate in a virtual tumor board involving difficult cases in the management of early breast cancer.
We welcome you to join one of the following Oncotype DX Virtual Tumor Board web conferences taking place on:
-
Tuesday, September 22, 2009 5:00 PM (PDT)/ 6:00 PM (MDT)/ 7:00 PM (CDT)/ 8:00 PM (EDT)
- Thursday, September 24, 2009 10:00 AM (PDT)/ 11:00 AM (MDT)/ 12:00 PM (CDT)/ 1:00 PM (EDT)
Meeting Objectives
-
To discuss important and controversial issues in the diagnosis, treatment, and management of patients with early stage breast cancer including:
-
Patient with a large tumor
-
Patient with lymph node positive disease
Virtual Tumor Board Faculty
-
Dr. Kevin Fox, The Abramson Cancer Center, University of Pennsylvania
-
Dr. Christy Russell, Keck School of Medicine, University of Southern California
-
Dr. Baljit Singh, New York University Cancer Institute, New York University
-
Dr. Pat Whitworth, Nashville Breast Center, Nashville, TN
These web conferences are part of Genomic Health’s effort to provide ongoing
education for members of the breast cancer community, including oncologists,
surgeons, and pathologists. These web conferences will provide a forum for discussion of actual patient case studies and current best practices in diagnosis, treatment, and management of patients with early stage breast cancer. Patient cases will focus on patients who have tumor characteristics making adjuvant decision-making difficult. The presentations and interactive discussions will be led by experts in the field who will be ready to answer your questions in order to support your education and that of your peers.
If you would like to submit a case for discussion, please go to:
http://www.oncotypedxcsi.com.
With your participation, we hope to continue improving the clinical outcomes and quality of life of patients diagnosed with breast cancer.
Sincerely,
Gary Palmer, MD, JD, MBA, MPH
Vice President, Medical Affairs
Genomic Health, Inc. |
